Related Experiment Video
Updated: Apr 19, 2026
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
14.9K
Resemble and Inhibit: when RLR meets TGF-β
Shu Zhu1, Hua-Bing Li1, Richard A Flavell2
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Molecular Cell
|December 20, 2014
Summary
Innate antiviral signaling via RIG-I-like receptors (RLR) blocks TGF-β effects. This pathway, involving IRF3, inhibits cell growth, EMT, and regulatory T cell differentiation.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-β) is a key regulator of cell growth, differentiation, and immune responses.
- Epithelial-mesenchymal transition (EMT) is a process crucial for development and implicated in cancer metastasis.
- Regulatory T cells (Tregs) play a vital role in maintaining immune tolerance.
Purpose of the Study:
- To investigate the interplay between innate antiviral signaling and TGF-β-induced cellular processes.
- To elucidate the molecular mechanisms by which RIG-I-like receptors (RLR) signaling influences TGF-β pathways.
- To determine the role of IRF3 and Smad proteins in mediating these interactions.
Main Methods:
- Utilized cell culture models to study TGF-β-induced responses.
- Employed molecular biology techniques to analyze RLR signaling activation.
- Investigated the expression and function of IRF3 and Smad proteins under different signaling conditions.
Main Results:
- Innate antiviral RLR signaling was found to repress TGF-β-induced growth inhibition.
- RLR signaling also suppressed TGF-β-mediated epithelial-mesenchymal transition (EMT).
- The differentiation of regulatory T cells (Tregs) induced by TGF-β was inhibited by RLR signaling through IRF3-mediated Smad function.
Conclusions:
- Innate antiviral immunity, through RLRs and IRF3, acts as a negative regulator of TGF-β signaling.
- This crosstalk impacts fundamental cellular processes including growth, EMT, and Treg differentiation.
- Understanding this pathway offers insights into immune regulation and potential therapeutic targets.
Related Concept Videos
01:16TGF - β Signaling Pathway
11.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
01:24T Cell Types and Functions
3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K
01:26Receptor Tyrosine Kinases
21.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
21.3K
01:24Small GTPases - Ras and Rho
5.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.8K
01:29The Two-State Receptor Model
3.6K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.6K
01:15Receptor Downregulation in MVBs
3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
3.0K